SCHEMBL17628231

SCHEMBL17628231

CC(=O)NC1CCCN(c2nc(Cl)nc3c2CCC3)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.46
AKT1 P31749 1/20 0.40
PIK3CA P42336 2/20 0.39
MTOR P42345 2/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
PRKDC P78527 2/20 0.37
BTK Q06187 2/20 0.37
OPRM1 P35372 2/20 0.37
OPRD1 P41143 2/20 0.37
OPRK1 P41145 2/20 0.37
OGFRL1 Q5TC84 2/20 0.37
JAK3 P52333 1/20 0.37
ROCK1 Q13464 1/20 0.36
CDC42BPB Q9Y5S2 1/20 0.36
CNR2 P34972 1/20 0.36
MTNR1A P48039 2/20 0.36
MTNR1B P49286 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17628230 1.00 HRH4 (0.46) HRH4AKT1PIK3CAMTORCA1
SCHEMBL17628039 0.98 HRH4 (0.46) HRH4AKT1PIK3CAMTORCA1
SCHEMBL17628042 0.98 HRH4 (0.46) HRH4AKT1PIK3CAMTORCA1
SCHEMBL17628108 0.94 HRH4 (0.53) HRH4AKT1OPRM1OPRD1OPRK1
SCHEMBL17628110 0.94 HRH4 (0.53) HRH4AKT1OPRM1OPRD1OPRK1
SCHEMBL17628467 0.92 HRH4 (0.53) HRH4AKT1OPRM1OPRD1OPRK1
SCHEMBL17628466 0.92 HRH4 (0.53) HRH4AKT1OPRM1OPRD1OPRK1
SCHEMBL17628018 0.90 HRH4 (0.45) HRH4PRKDCBTKOPRM1OPRK1
SCHEMBL17628112 0.87 HRH4 (0.45) HRH4PRKDCBTKOPRM1OPRK1
SCHEMBL17628082 0.84 HRH4 (0.51) HRH4AKT1OPRM1OPRK1OGFRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORPORATION (KR) 2017-06-01 US disclosed
EP-3006439-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR Yuhan Corporation (KR) 2016-04-13 EP disclosed
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR YUHAN CORP (KR) 2016-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152241-A9 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 HRH4 4/4885AKT1 2912/4885PIK3CA 446/4885
US-20160090374-A1 BICYCLIC DERIVATIVE CONTAINING PYRIMIDINE RING, AND PREPARATION METHOD THEREFOR GPR119, GIPR, P2RY4 HRH4 4/4885AKT1 2912/4885PIK3CA 446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.